According to a new report from Intel Market Research, the Europe BFS (Blow‑Fill‑Seal) Products market was valued at USD 2.01 billion in 2024 and is projected to grow from USD 2.24 billion in 2025 to USD 4.37 billion by 2032, exhibiting a robust CAGR of 11.5% during the forecast period (2025–2032). This expansion is driven by the continent’s mature pharmaceutical ecosystem, stringent...

According to a new report from Intel Market Research, the global Biopharmaceutical and Bio-CDMO market was valued at USD 25.71 billion in 2024 and is projected to grow from USD 28.95 billion in 2025 to USD 63.88 billion by 2032, exhibiting a robust CAGR of 14.2% during the forecast period (2025–2032). This growth is driven by increasing demand for biologics and biosimilars due to their...

 According to a newly published market research report by 24LifeSciences, global Haemophilus Influenzae Type b Conjugate Vaccine market was valued at USD 1.25 billion in 2025 and is projected to reach USD 2.41 billion by 2034, growing at a compound annual growth rate (CAGR) of 7.6% during the forecast period 20262034. Haemophilus Influenzae Type...

Global Medical Polyisoprene Rubber Gasket Market was valued at USD 258 million in 2023 and is projected to reach USD 421.30 million by 2032, expanding at a CAGR of 5.60% during the forecast period. Growing demand for pharmaceutical packaging components, injectable drug delivery systems, medical devices, and biopharmaceutical manufacturing continues to accelerate adoption of medical-grade...

The United States Single Use Tubing Market continues to demonstrate strong growth momentum, reaching a valuation of USD 342.8 million in 2024 and projected to grow to approximately USD 524.6 million by 2030, expanding at a CAGR of 7.3% during the forecast period. Growing adoption of single-use technologies across biopharmaceutical manufacturing, vaccine production, cell and gene...

The United States is a key contributor to the inactivated vaccines market, supported by its advanced healthcare infrastructure, strong immunization programs, and significant investments in vaccine research and development. The presence of leading pharmaceutical companies, growing focus on infectious disease prevention, and increasing adoption of adult vaccination programs continue to drive...

The United States represents the largest share of the North American Pharmaceutical Filtration System Market, driven by its well-established pharmaceutical and biotechnology industries, robust research infrastructure, and strong regulatory framework. The presence of leading pharmaceutical manufacturers, biotechnology firms, and contract development and manufacturing organizations (CDMOs) has...